LyondellBasell Industries (NYSE: LYB) today announced results for
the fourth quarter 2024 and full year 2024. Comparisons with the
prior quarter, fourth quarter 2023 and full year 2023 are available
in the following table:
Table 1 - Earnings Summary
Millions of U.S. dollars (except share data) |
|
Three Months Ended |
Year Ended |
|
December 31,2024 |
September 30,2024 |
December 31,2023 |
December 31,2024 |
December 31,2023 |
Sales and other operating revenues |
|
$ |
9,497 |
|
$ |
10,322 |
|
$ |
9,929 |
|
$ |
40,302 |
|
$ |
41,107 |
|
Net (loss) income |
|
|
(603 |
) |
|
573 |
|
|
185 |
|
|
1,367 |
|
|
2,121 |
|
Diluted (loss) earnings per share |
|
|
(1.87 |
) |
|
1.75 |
|
|
0.56 |
|
|
4.15 |
|
|
6.46 |
|
Weighted average diluted share count |
|
|
325 |
|
|
326 |
|
|
326 |
|
|
326 |
|
|
326 |
|
EBITDA3 |
|
|
(409 |
) |
|
1,174 |
|
|
639 |
|
|
3,456 |
|
|
4,509 |
|
Excluding Identified
Items3
Net income excluding identified items |
|
$ |
249 |
|
$ |
617 |
|
$ |
411 |
|
$ |
2,101 |
|
$ |
2,838 |
|
Diluted earnings per share excluding identified items |
|
|
0.75 |
|
|
1.88 |
|
|
1.26 |
|
|
6.40 |
|
|
8.65 |
|
Gain on sale of business, pre-tax |
|
|
9 |
|
|
— |
|
|
— |
|
|
(284 |
) |
|
— |
|
Asset write-downs, pre-tax |
|
|
1,065 |
|
|
— |
|
|
241 |
|
|
1,065 |
|
|
518 |
|
Refinery exit costs, pre-tax |
|
|
44 |
|
|
57 |
|
|
50 |
|
|
179 |
|
|
334 |
|
EBITDA excluding identified items |
|
|
689 |
|
|
1,211 |
|
|
910 |
|
|
4,336 |
|
|
5,222 |
|
“During the fourth quarter, our businesses
delivered excellent cash performance amid difficult market
conditions. Our strong cash generation and robust balance sheet
enabled us to achieve meaningful progress on our strategic goals to
drive profitable and sustainable growth at LyondellBasell. I am
very proud of our team's progress in building a profitable Circular
& Low Carbon Solutions business, where volumes grew by 65%
during 2024,” said Peter Vanacker, LYB Chief Executive Officer.
FOURTH QUARTER 2024 RESULTSThe
company reported a net loss for the fourth quarter 2024 of $603
million, or $1.87 per share. During the quarter, the company
recognized identified items of $852 million, net of tax. These
items, which impacted earnings by $2.62 per share, included
non-cash asset write-downs related to our O&P Europe, Asia and
International (O&P EAI) and Advanced Polymer Solutions (APS)
segments of $769 million and $42 million respectively, and costs
incurred from plans to exit the refining business. The write-downs
reflect the challenging market conditions for these businesses and
include assets in our European strategic review and an Asian joint
venture in our O&P EAI segment and the Specialty Powders
business in our APS segment. Fourth quarter 2024 EBITDA was $(409)
million, or $689 million excluding identified items. In addition to
the identified items, non-cash LIFO inventory valuation charges
impacted pre-tax quarterly results by approximately $23
million.
Fourth quarter margins declined across most
businesses as costs for NGL feedstocks and natural gas increased
while product prices were restrained by seasonally slower demand.
Robust export demand for North American polyethylene offset some
seasonal volume moderation in domestic markets. Sequentially higher
ethane raw material costs led to lower integrated polyethylene
margins. Outside of North America, seasonally slower demand for
olefins and polyolefins and downtime at the company's European
assets impacted volumes and margins. Significantly lower gasoline
crack spreads reduced refining and oxyfuels margins as well as the
value of co-product fuels in the Olefins & Polyolefins
segments.
FULL YEAR 2024 RESULTSFull year
2024 net income was $1.4 billion, or $4.15 per share. During the
year, the company recognized identified items of $734 million, net
of tax. These items, which impacted full year earnings by $2.25 per
share included non-cash asset write-downs, costs incurred from
exiting the refining business and the gain on sale of the Ethylene
Oxide and Derivatives business. Full year 2024 EBITDA was $3.5
billion, or $4.3 billion excluding identified items.
LYB generated $3.8 billion in cash from operating
activities during 2024. The company remains committed to a
disciplined capital allocation approach. In 2024, approximately
$1.8 billion was reinvested in the business through capital
expenditures while $1.9 billion was returned to shareholders
through quarterly dividends and share repurchases. The company
maintains a robust investment-grade balance sheet with $8.0 billion
of available liquidity, including $3.4 billion of cash and cash
equivalents, at year-end.
Throughout 2024, petrochemical markets faced
headwinds from soft global demand, rising raw material costs and
economic uncertainty. Markets were broadly pressured by weak demand
for durable goods, which impacted margins in the company's Olefins
& Polyolefins and Intermediates & Derivatives segments.
Margin recovery in the company's Advanced Polymer Solutions segment
was limited by global declines in automotive production. LYB
continues to be well-positioned to navigate challenging markets and
generate strong cash returns.
STRATEGY HIGHLIGHTS“LyondellBasell
is successfully navigating difficult market conditions while
delivering excellent cash performance during what has been the
longest and deepest downturn of my career. And we are not wavering
in the execution of our strategy. We continue to grow and upgrade
our core businesses with decisive portfolio management. The volumes
of our sustainable products are rapidly growing and aligned with
our profitability targets. We are sharpening our focus on value
creation while diligently managing and tracking our progress
through a highly disciplined Value Enhancement Program. With a
robust investment-grade balance sheet, LYB is well-positioned to
deliver on our strategic promises and reward shareholders with a
growing dividend as part of our overall value proposition," said
Vanacker.
The company's strategy, outlined at its 2023
Capital Markets Day, is focused on generating value-added growth to
deliver $3 billion of incremental Normalized EBITDA by 20274. By
the end of 2024, LYB unlocked approximately $1.3 billion of
incremental Normalized EBITDA, primarily from the successful
start-up of new PO/TBA capacity and its Value Enhancement Program.
During 2025, LYB expects to unlock additional profitability from
the Value Enhancement Program, transformation of the Advanced
Polymer Solutions business, growth of the company's CLCS business,
as well as further organic and inorganic growth initiatives.
In the two years following the company's Capital
Markets Day, additional market headwinds have emerged that are
partially offsetting some of this progress. Amid these headwinds,
LYB has remained strongly positioned, with a focus on
cost-advantaged feedstocks, a robust balance sheet and a strong
commitment to cash returns for shareholders.
OUTLOOKEntering 2025, LYB remains
watchful and prepared for the macroeconomic catalysts that will
eventually drive restocking of supply chains, improve demand for
durable goods and support a more broad-based economic recovery. One
indicator of recovery is that North American domestic demand for
polyolefins rebounded in 2024, after two years of declines. The
company expects seasonal demand improvements to emerge across most
product lines during the first quarter. Reductions in interest
rates, moderation of inflation and pent-up demand should be
supportive for increased consumption of durable goods, benefiting
the company's polypropylene and Intermediates and Derivatives
businesses. Increased driving and summertime gasoline
specifications should lead to typical seasonal improvements in
oxyfuels margins. LYB expects a gradual recovery in oxyfuel margins
over the summer months, with strong octane premiums and the
relatively low cost of butane raw materials supportive of long-term
oxyfuels fundamentals. Tariff and trade uncertainties are potential
headwinds. Consistent with the company's prior guidance, refining
operations will cease in the first quarter of 2025, a strategic
milestone paving the way for continued growth in circular and
low-carbon feedstocks and products.
LYB is aligning first quarter operating rates with
global demand and expects to operate Olefins & Polyolefins
Americas assets at approximately 80%, Olefins & Polyolefins EAI
assets at approximately 75%, and Intermediates & Derivatives
assets at approximately 80%.
________________________1 Cash conversion is
net cash provided by operating activities divided by EBITDA
excluding adjustments for lower of cost or market (“LCM”), gain on
sale of business and asset write-downs in excess of $10 million in
aggregate for the period.2 Volumes produced and marketed includes:
(i) joint venture production marketed by LYB plus our pro rata
share of the remaining production produced and marketed by the
joint venture, and (ii) production via third-party tolling
arrangements.3 See “Information Related to Financial Measures” for
a discussion of the company’s use of non-GAAP financial measures
and Tables 2-11 for reconciliations or calculations of these
financial measures. “Identified items” include LCM, gain on sale of
business, asset write-downs in excess of $10 million in aggregate
for the period and refinery exit costs.4 2027 incremental
Normalized EBITDA reflects expected improvement over a 2022
year-end asset portfolio with 2013-2022 historical average margins
and operating rates and the benefits associated with our strategic
initiatives. Please see “Information Related to Financial Measures”
for additional information on Normalized EBITDA.
CONFERENCE CALLLYB will host a
conference call January 31 at 11 a.m. EST. Participants on the call
will include Chief Executive Officer Peter Vanacker, Executive Vice
President and Chief Financial Officer Michael McMurray, Executive
Vice President of Global Olefins and Polyolefins and Refining Kim
Foley, Executive Vice President of Intermediates and Derivatives
Aaron Ledet, Executive Vice President of Advanced Polymer Solutions
Torkel Rhenman and Head of Investor Relations David Kinney. For
event access, the toll-free dial-in number is 1-877-407-8029,
international dial-in number is 201-689-8029 or click the CallMe
link. The slides and webcast that accompany the call will be
available at investors.lyondellbasell.com/earnings. A replay of the
call will be available from 1:00 p.m. EST January 31 until March 2.
The replay toll-free dial-in numbers are 1-877-660-6853 and
201-612-7415. The access ID for each is 13746203.
ABOUT LYONDELLBASELLWe are
LyondellBasell (NYSE: LYB) – a leader in the global chemical
industry creating solutions for everyday sustainable living.
Through advanced technology and focused investments, we are
enabling a circular and low carbon economy. Across all we do, we
aim to unlock value for our customers, investors and society. As
one of the world's largest producers of polymers and a leader in
polyolefin technologies, we develop, manufacture and market
high-quality and innovative products for applications ranging from
sustainable transportation and food safety to clean water and
quality healthcare. For more information, please visit
www.LyondellBasell.com or follow @LyondellBasell on
LinkedIn.
FORWARD-LOOKING
STATEMENTSThe statements in this release relating to
matters that are not historical facts are forward-looking
statements. These forward-looking statements are based upon
assumptions of management of LyondellBasell which are believed to
be reasonable at the time made and are subject to significant risks
and uncertainties. When used in this release, the words “estimate,”
“believe,” “continue,” “could,” “intend,” “may,” “plan,”
“potential,” “predict,” “should,” “will,” “expect,” and similar
expressions are intended to identify forward-looking statements,
although not all forward-looking statements contain such
identifying words. Actual results could differ materially based on
factors including, but not limited to, market conditions; the
business cyclicality of the chemical, polymers and refining
industries; the availability, cost and price volatility of raw
materials and utilities, particularly the cost of oil, natural gas,
and associated natural gas liquids; our ability to successfully
implement initiatives identified pursuant to our Value Enhancement
Program and generate anticipated earnings; competitive product and
pricing pressures; labor conditions; our ability to attract and
retain key personnel; operating interruptions (including leaks,
explosions, fires, weather-related incidents, mechanical failure,
unscheduled downtime, supplier disruptions, labor shortages,
strikes, work stoppages or other labor difficulties, transportation
interruptions, spills and releases and other environmental risks);
the supply/demand balances for our and our joint ventures’
products, and the related effects of industry production capacities
and operating rates; our ability to manage costs; future financial
and operating results; our ability to align our assets and grow and
upgrade our core, including the results of our strategic review of
certain European assets; legal and environmental proceedings; tax
rulings, consequences or proceedings; technological developments,
and our ability to develop new products and process technologies;
our ability to meet our sustainability goals, including the ability
to operate safely, increase production of recycled and
renewable-based polymers to meet our targets and forecasts, and
reduce our emissions and achieve net zero emissions by the time set
in our goals; our ability to procure energy from renewable sources;
our ability to build a profitable Circular & Low Carbon
Solutions business; the continued operation of and successful shut
down and closure of the Houston Refinery, including within the
expected timeframe; potential governmental regulatory actions;
political unrest and terrorist acts; risks and uncertainties posed
by international operations, including foreign currency
fluctuations; and our ability to comply with debt covenants and to
repay our debt. Additional factors that could cause results to
differ materially from those described in the forward-looking
statements can be found in the “Risk Factors” section of our Form
10-K for the year ended December 31, 2023, which can be found at
www.LyondellBasell.com on the Investor Relations page and on
the Securities and Exchange Commission’s website at www.sec.gov.
There is no assurance that any of the actions, events or results of
the forward-looking statements will occur, or if any of them do,
what impact they will have on our results of operations or
financial condition. Forward-looking statements speak only as of
the date they were made and are based on the estimates and opinions
of management of LyondellBasell at the time the statements are
made. LyondellBasell does not assume any obligation to update
forward-looking statements should circumstances or management’s
estimates or opinions change, except as required by law.
This release contains time sensitive information
that is accurate only as of the date hereof. Information contained
in this release is unaudited and is subject to change. We undertake
no obligation to update the information presented herein except as
required by law.
INFORMATION RELATED TO FINANCIAL
MEASURESThis release makes reference to certain non-GAAP
financial measures as defined in Regulation G of the U.S.
Securities Exchange Act of 1934, as amended.
We report our financial results in accordance with
U.S. generally accepted accounting principles, but believe that
certain non-GAAP financial measures, such as EBITDA, and EBITDA,
net income and diluted EPS exclusive of identified items provide
useful supplemental information to investors regarding the
underlying business trends and performance of the company's ongoing
operations and are useful for period-over-period comparisons of
such operations. Non-GAAP financial measures should be considered
as a supplement to, and not as a substitute for, or superior to,
the financial measures prepared in accordance with GAAP.
We calculate EBITDA as income from continuing
operations plus interest expense (net), provision for (benefit
from) income taxes, and depreciation and amortization. EBITDA
should not be considered an alternative to profit or operating
profit for any period as an indicator of our performance, or as an
alternative to operating cash flows as a measure of our liquidity.
We also present EBITDA, net income and diluted EPS exclusive of
identified items. Identified items include adjustments for “lower
of cost or market" (“LCM”), gain on sale of business, asset
write-downs in excess of $10 million in aggregate for the period
and refinery exit costs. Asset write-downs include impairments of
goodwill, impairments of long-lived assets, a write down of a
related party loan receivable and a fourth quarter 2024 deferred
tax valuation allowance for one of our Asian joint ventures
recognized in Income (loss) from equity investments. Our
inventories are stated at the lower of cost or market. Cost is
determined using the last-in, first-out (“LIFO”) inventory
valuation methodology, which means that the most recently incurred
costs are charged to cost of sales and inventories are valued at
the earliest acquisition costs. Fluctuation in the prices of crude
oil, natural gas and correlated products from period to period may
result in the recognition of charges to adjust the value of
inventory to the lower of cost or market in periods of falling
prices and the reversal of those charges in subsequent interim
periods, within the same fiscal year as the charge, as market
prices recover. A gain or loss on sale of a business is calculated
as the consideration received from the sale less its carrying
value. Property, plant and equipment are recorded at historical
costs. If it is determined that an asset or asset group’s
undiscounted future cash flows will not be sufficient to recover
the carrying amount, an impairment charge is recognized to write
the asset down to its estimated fair value. Goodwill is tested for
impairment annually in the fourth quarter or whenever events or
changes in circumstances indicate that the fair value of a
reporting unit with goodwill is below its carrying amount. If it is
determined that the carrying value of the reporting unit including
goodwill exceeds its fair value, an impairment charge is
recognized. We assess our equity investments for impairment
whenever events or changes in circumstances indicate that the
carrying amount of the investment may not be recoverable. If the
decline in value is considered to be other than temporary the
investment is written down to its estimated fair value. Valuation
allowances are provided against deferred tax assets when it is more
likely than not that some portion or all of the deferred tax asset
will not be realized. In April 2022, we announced our decision
to cease operation of our Houston Refinery. In connection with
exiting the refinery business, we began to incur costs primarily
consisting of accelerated lease amortization costs, personnel
related costs, accretion of asset retirement obligations,
depreciation of asset retirement costs and other charges.
Recurring annual EBITDA for the Value Enhancement
Program is the year-end EBITDA run rate estimated based on
2017-2019 mid-cycle margins and modest inflation relative to a 2021
baseline. We believe recurring annual EBITDA is useful to investors
because it represents a key measure used by management to assess
progress towards our strategy of value creation.
Normalized EBITDA assumes 2013-2022 historical
average margins and operating rates and reflects the benefits
associated with the following strategic initiatives: Grow &
Upgrade the Core, Building a Profitable CLCS Business and Step Up
Performance & Culture. Incremental Normalized EBITDA cannot be
reconciled to net income due to the inherent difficulty in
quantifying certain amounts that are necessary for such
reconciliation at the strategic initiative level, including
adjustments that could be made for interest expense (net),
provision for (benefit from) income taxes and depreciation &
amortization, the amounts of which, based on historical experience,
could be significant. We believe Normalized EBITDA and incremental
Normalized EBITDA are useful to investors because they represent
key measures used by management to assess progress towards our
overall company strategy.
Cash conversion is a measure commonly used by
investors to evaluate liquidity. Cash conversion means net cash
provided by operating activities divided by EBITDA excluding LCM,
gain on sale of business and asset write-downs in excess of $10
million in aggregate for the period. We believe cash conversion is
an important financial metric as it helps management and other
parties determine how efficiently the company is converting
earnings into cash.
These non-GAAP financial measures as presented
herein, may not be comparable to similarly titled measures reported
by other companies due to differences in the way the measures are
calculated. In addition, we include calculations for certain other
financial measures to facilitate understanding. This release
contains time sensitive information that is accurate only as of the
time hereof. Information contained in this release is unaudited and
subject to change.
LyondellBasell undertakes no obligation to update
the information presented herein except to the extent required by
law.
Additional operating and financial information may
be found on our website at investors.lyondellbasell.com.
Source: LyondellBasell Industries
Media Contact: Monica Silva +1 713-309-7575Investor
Contact: David Kinney +1 713-309-7141
|
Table 2 - Reconciliations of Net Income to Net Income
Excluding Identified Items and to EBITDA Including and Excluding
Identified Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Year Ended |
Millions of U.S. dollars |
|
December 31,2024 |
|
September 30,2024 |
|
December 31,2023 |
|
December 31,2024 |
|
December 31,2023 |
Net (loss) income |
|
$ |
(603 |
) |
|
$ |
573 |
|
|
$ |
185 |
|
|
$ |
1,367 |
|
|
$ |
2,121 |
|
Identified items |
|
|
|
|
|
|
|
|
|
|
less: Gain on sale of business, pre-tax(a) |
|
|
9 |
|
|
|
— |
|
|
|
— |
|
|
|
(284 |
) |
|
|
— |
|
add: Asset write-downs, pre-tax(b) |
|
|
1,065 |
|
|
|
— |
|
|
|
241 |
|
|
|
1,065 |
|
|
|
518 |
|
add: Refinery exit cost, pre-tax(c) |
|
|
44 |
|
|
|
57 |
|
|
|
50 |
|
|
|
179 |
|
|
|
334 |
|
add: Benefit from income taxes related to identified items |
|
|
(266 |
) |
|
|
(13 |
) |
|
|
(65 |
) |
|
|
(226 |
) |
|
|
(135 |
) |
Net income excluding identified items |
|
$ |
249 |
|
|
$ |
617 |
|
|
$ |
411 |
|
|
$ |
2,101 |
|
|
$ |
2,838 |
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(603 |
) |
|
$ |
573 |
|
|
$ |
185 |
|
|
$ |
1,367 |
|
|
$ |
2,121 |
|
(Income) loss from discontinued operations, net of tax |
|
|
(10 |
) |
|
|
4 |
|
|
|
1 |
|
|
|
(4 |
) |
|
|
5 |
|
(Loss) income from continuing operations |
|
|
(613 |
) |
|
|
577 |
|
|
|
186 |
|
|
|
1,363 |
|
|
|
2,126 |
|
(Benefit from) provision for income taxes |
|
|
(265 |
) |
|
|
134 |
|
|
|
(7 |
) |
|
|
240 |
|
|
|
501 |
|
Depreciation and amortization(d) |
|
|
389 |
|
|
|
381 |
|
|
|
380 |
|
|
|
1,522 |
|
|
|
1,534 |
|
Interest expense, net |
|
|
80 |
|
|
|
82 |
|
|
|
80 |
|
|
|
331 |
|
|
|
348 |
|
EBITDA |
|
|
(409 |
) |
|
|
1,174 |
|
|
|
639 |
|
|
|
3,456 |
|
|
|
4,509 |
|
Identified items |
|
|
|
|
|
|
|
|
|
|
less: Gain on sale of business(a) |
|
|
9 |
|
|
|
— |
|
|
|
— |
|
|
|
(284 |
) |
|
|
— |
|
add: Asset write-downs(b) |
|
|
1,065 |
|
|
|
— |
|
|
|
241 |
|
|
|
1,065 |
|
|
|
518 |
|
add: Refinery exit costs(e) |
|
|
24 |
|
|
|
37 |
|
|
|
30 |
|
|
|
99 |
|
|
|
195 |
|
EBITDA excluding identified items |
|
$ |
689 |
|
|
$ |
1,211 |
|
|
$ |
910 |
|
|
$ |
4,336 |
|
|
$ |
5,222 |
|
|
|
|
|
|
|
|
|
|
|
|
(a) In 2024, we sold our U.S. Gulf Coast-based
Ethylene Oxide and Derivatives ("EO&D") business, resulting in
the recognition of a gain, including fourth quarter post close
adjustments, in our Intermediates & Derivatives ("I&D")
segment.(b) Includes asset write-downs in excess of $10 million in
aggregate for the period. The year ended December 31, 2024 reflects
non-cash asset write-downs of $1,065 million, which includes a
non-cash impairment charge of $837 million related to European
assets under strategic review in our Olefins & Polyolefins –
Europe, Asia & International ("O&P-EAI") segment, non-cash
impairment charges and the recognition of a deferred tax valuation
allowance of $52 million and $121 million, respectively, related to
our Asian equity investment in our O&P-EAI segment, and a
non-cash impairment charge of $55 million related to our specialty
powders business in our Advanced Polymer Solutions ("APS") segment,
recognized in the fourth quarter of 2024. The year ended December
31, 2023 reflects non-cash impairment charges of $518 million,
which includes a non-cash goodwill impairment charge of $252
million in our APS segment, recognized in the first quarter of
2023, and a non-cash impairment charge of $192 million related to
our Dutch PO/SM joint venture assets in our I&D segment,
recognized in the fourth quarter of 2023.(c) Refinery exit costs
include accelerated lease amortization costs, personnel related
costs, accretion of asset retirement obligations, depreciation of
asset retirement costs and other charges. See Table 10 for
additional detail on refinery exit costs.(d) Depreciation and
amortization includes depreciation of asset retirement costs in
connection with exiting the Refining business. See Table 10 for
additional detail on refinery exit costs.(e) Refinery exit costs
include accelerated lease amortization costs, personnel related
costs, accretion of asset retirement obligations and other charges.
See Table 10 for additional detail on refinery exit costs.
Table 3 - Reconciliation of Diluted EPS to Diluted EPS
Excluding Identified Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Year Ended |
|
|
December 31,2024 |
|
September 30,2024 |
|
December 31,2023 |
|
December 31,2024 |
|
December 31,2023 |
Diluted (loss) earnings per share |
|
$ |
(1.87 |
) |
|
$ |
1.75 |
|
|
$ |
0.56 |
|
|
$ |
4.15 |
|
|
$ |
6.46 |
|
Identified items |
|
|
|
|
|
|
|
|
|
|
less: Gain on sale of business |
|
|
0.02 |
|
|
|
— |
|
|
|
— |
|
|
|
(0.66 |
) |
|
|
— |
|
add: Asset write-downs(a) |
|
|
2.50 |
|
|
|
— |
|
|
|
0.59 |
|
|
|
2.49 |
|
|
|
1.41 |
|
add: Refinery exit costs |
|
|
0.10 |
|
|
|
0.13 |
|
|
|
0.11 |
|
|
|
0.42 |
|
|
|
0.78 |
|
Diluted earnings per share excluding identified items |
|
$ |
0.75 |
|
|
$ |
1.88 |
|
|
$ |
1.26 |
|
|
$ |
6.40 |
|
|
$ |
8.65 |
|
|
|
|
|
|
|
|
|
|
|
|
(a) Includes asset write-downs in excess of $10
million in aggregate for the period.
Table 4 - Reconciliation of Net Cash Provided by Operating
Activities to EBITDA Including and Excluding LCM, Gain on Sale of
Business and Asset Write-Downs |
|
|
|
|
|
Year Ended |
Millions of U.S. dollars |
|
December 31,2024 |
Net cash provided by operating activities |
|
$ |
3,819 |
|
Adjustments: |
|
|
Depreciation and amortization |
|
|
(1,522 |
) |
Impairments |
|
|
(949 |
) |
Amortization of debt-related costs |
|
|
(11 |
) |
Share-based compensation |
|
|
(91 |
) |
Equity loss, net of distributions of earnings |
|
|
(339 |
) |
Deferred income tax benefit |
|
|
437 |
|
Gain on sale of business |
|
|
284 |
|
Changes in assets and liabilities that (provided) used cash: |
|
|
Accounts receivable |
|
|
(127 |
) |
Inventories |
|
|
(25 |
) |
Accounts payable |
|
|
122 |
|
Other, net |
|
|
(231 |
) |
Net income |
|
|
1,367 |
|
Income from discontinued operations, net of tax |
|
|
(4 |
) |
Income from continuing operations |
|
|
1,363 |
|
Provision for income taxes |
|
|
240 |
|
Depreciation and amortization |
|
|
1,522 |
|
Interest expense, net |
|
|
331 |
|
EBITDA |
|
|
3,456 |
|
add: LCM charges |
|
|
— |
|
less: Gain on sale of business(a) |
|
|
(284 |
) |
add: Asset write-downs(b) |
|
|
1,065 |
|
EBITDA excluding LCM, gain on sale of business and asset
write-downs |
|
$ |
4,237 |
|
|
|
|
(a) In 2024, we sold our U.S. Gulf Coast-based
EO&D business, resulting in the recognition of a gain,
including fourth quarter post close adjustments, in our I&D
segment.(b) Includes asset write-downs in excess of $10 million in
aggregate for the period. The year ended December 31, 2024 reflects
non-cash asset write-downs of $1,065 million, which includes a
non-cash impairment charge of $837 million related to European
assets under strategic review in our O&P-EAI segment, non-cash
impairment charges and the recognition of a deferred tax valuation
allowance of $52 million and $121 million, respectively, related to
our Asian equity investment in our O&P-EAI segment, and a
non-cash impairment charge of $55 million related to our specialty
powders business in our APS segment, recognized in the fourth
quarter of 2024.
Table 5 - Calculation of Cash Conversion |
|
|
|
|
|
Year Ended |
Millions of U.S. dollars |
|
December 31,2024 |
Net cash provided by operating activities |
|
$ |
3,819 |
|
divided by: |
|
|
EBITDA excluding LCM, gain on sale of business and asset
write-downs(a) |
|
$ |
4,237 |
|
Cash conversion |
|
|
90 |
% |
|
|
|
(a) See Table 4 for a reconciliation of net cash
provided by operating activities to EBITDA including and excluding
LCM, gain on sale of business and asset write-downs in excess of
$10 million in aggregate for the period.
Table 6 - Calculation of Cash and Liquid Investments and
Total Liquidity |
|
|
|
Millions of U.S. dollars |
|
December 31,2024 |
Cash and cash equivalents and restricted cash |
|
$ |
3,388 |
|
Short-term investments |
|
|
— |
|
Cash and liquid investments |
|
$ |
3,388 |
|
add: |
|
|
Availability under Senior Revolving Credit Facility |
|
|
3,750 |
|
Availability under U.S. Receivables Facility |
|
|
900 |
|
Total liquidity |
|
$ |
8,038 |
|
|
|
|
Table 7 - Calculation of Dividends and Share
Repurchases |
|
|
|
|
|
Year Ended |
Millions of U.S. dollars |
|
December 31,2024 |
Dividends paid - common stock |
|
$ |
1,720 |
|
Repurchase of Company ordinary shares |
|
|
195 |
|
Dividends and share repurchases |
|
$ |
1,915 |
|
|
|
|
Table 8 - Calculation of Incremental Normalized
EBITDA |
|
|
|
|
|
UnlockedValue |
Millions of U.S. dollars |
|
|
2024 |
|
Recurring annual EBITDA from VEP(a) |
|
$ |
800 |
|
Mid-Cycle PO/TBA EBITDA(b) |
|
|
450 |
|
Total incremental Normalized EBITDA(c) |
|
$ |
1,250 |
|
|
|
|
(a) Year-end EBITDA run rate for 2024 based on
2017-2019 mid-cycle margins and modest inflation relative to 2021
baseline. See Table 9 for a reconciliation of net income to
recurring annual EBITDA for VEP.(b) Mid-Cycle PO/TBA EBITDA
represents nameplate capacity multiplied by 2017-2019 average cash
margins.(c) Incremental Normalized EBITDA reflects expected
improvement over a 2022 year-end asset portfolio with 2013-2022
historical average margins and operating rates and the benefits
associated with our strategic initiatives.
Table 9 - Reconciliation of Net Income to Recurring Annual
EBITDA for the Value Enhancement Program |
|
|
|
|
|
UnlockedValue |
Millions of U.S. dollars |
|
2024(b) |
Net income(a) |
|
$ |
610 |
|
Provision for income taxes |
|
|
155 |
|
Depreciation and amortization |
|
|
35 |
|
Interest expense, net |
|
|
— |
|
Recurring annual EBITDA(a) |
|
$ |
800 |
|
|
|
|
(a) Year-end run rate for 2024 based on 2017-2019
mid-cycle margins and modest inflation relative to 2021
baseline.(b) In 2024, VEP delivered a year-end run-rate of
approximately $800 million of recurring annual EBITDA.
Table 10 - Refinery Exit Costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Year Ended |
Millions of U.S. dollars |
|
December 31,2024 |
|
September 30,2024 |
|
December 31,2023 |
|
December 31,2024 |
|
December 31,2023 |
Refinery exit costs: |
|
|
|
|
|
|
|
|
|
|
Accelerated lease amortization costs |
|
$ |
10 |
|
|
$ |
10 |
|
|
$ |
10 |
|
|
$ |
38 |
|
|
$ |
110 |
|
Personnel costs |
|
|
12 |
|
|
|
7 |
|
|
|
17 |
|
|
|
35 |
|
|
|
76 |
|
Asset retirement obligation accretion |
|
|
2 |
|
|
|
2 |
|
|
|
3 |
|
|
|
8 |
|
|
|
9 |
|
Asset retirement cost depreciation |
|
|
20 |
|
|
|
20 |
|
|
|
20 |
|
|
|
80 |
|
|
|
139 |
|
Other charges |
|
|
— |
|
|
|
18 |
|
|
|
— |
|
|
|
18 |
|
|
|
— |
|
Total refinery exits costs |
|
$ |
44 |
|
|
$ |
57 |
|
|
$ |
50 |
|
|
$ |
179 |
|
|
$ |
334 |
|
|
|
|
|
|
|
|
|
|
|
|
Table 11 - Identified Items After-Tax |
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
December 31, 2024 |
Millions of U.S. dollars |
|
Pre-tax |
|
Tax effect |
|
After-tax |
Identified items: |
|
|
|
|
|
|
add: Gain on sale of business(a) |
|
|
|
|
|
|
Intermediates & Derivatives |
|
$ |
9 |
|
|
$ |
(2 |
) |
|
$ |
7 |
|
add: Asset write-downs(b) |
|
|
|
|
|
|
Olefins & Polyolefins - EAI |
|
|
1,010 |
|
|
|
(241 |
) |
|
|
769 |
|
Advanced Polymer Solutions |
|
|
55 |
|
|
|
(13 |
) |
|
|
42 |
|
add: Refinery exit costs |
|
|
|
|
|
|
Refining |
|
|
44 |
|
|
|
(10 |
) |
|
|
34 |
|
Total Identified items |
|
$ |
1,118 |
|
|
$ |
(266 |
) |
|
$ |
852 |
|
|
|
|
|
|
|
|
(a) Represents post close adjustment which reduced
the gain on sale of our EO&D business. (b) Includes asset
write-downs in excess of $10 million in aggregate for the
period.
LyondellBasell Industrie... (NYSE:LYB)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
LyondellBasell Industrie... (NYSE:LYB)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025